Header cover image

Taiwanese (TAIEX) Pharma Industry Analysis

UpdatedJun 30, 2022
DataAggregated Company Financials
Companies47
  • 7D0.4%
  • 3M-2.7%
  • 1Y4.6%
  • YTD1.3%

In the last week, the Pharma industry is up 3.5%, with Lotus Pharmaceutical leading the way, up 5.9%. During this same period, the Oneness Biotech underperformed, falling 11%. This takes the industry's 12 month performance to a gain of 7.0%. As for the next few years, earnings are expected to grow by 59% per annum.

Industry Valuation and Performance

Has the Taiwanese Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPE
Fri, 01 Jul 2022NT$409.1bNT$76.8bNT$4.4b21.6x
Sun, 29 May 2022NT$378.3bNT$76.8bNT$4.4b20.5x
Tue, 26 Apr 2022NT$392.7bNT$76.5bNT$6.5b21.6x
Thu, 24 Mar 2022NT$398.8bNT$76.6bNT$8.9b20.7x
Sat, 19 Feb 2022NT$404.2bNT$76.7bNT$8.5b19.3x
Mon, 17 Jan 2022NT$370.8bNT$76.7bNT$8.5b18.8x
Wed, 15 Dec 2021NT$390.8bNT$76.7bNT$8.5b18.4x
Fri, 12 Nov 2021NT$362.1bNT$75.7bNT$10.1b17.3x
Sun, 10 Oct 2021NT$348.0bNT$76.0bNT$10.7b18.9x
Tue, 07 Sep 2021NT$358.0bNT$76.0bNT$10.7b19.7x
Thu, 05 Aug 2021NT$367.5bNT$76.0bNT$10.7b21.4x
Sun, 09 May 2021NT$358.3bNT$74.2bNT$12.5b18.7x
Wed, 10 Feb 2021NT$300.3bNT$72.4bNT$8.6b17.1x
Tue, 03 Nov 2020NT$356.2bNT$71.7bNT$6.3b18.5x
Fri, 07 Aug 2020NT$328.7bNT$70.9bNT$5.6b20.6x
Thu, 30 Apr 2020NT$231.6bNT$70.2bNT$1.8b22.3x
Sun, 02 Feb 2020NT$224.7bNT$69.7bNT$1.3b21.6x
Wed, 06 Nov 2019NT$231.9bNT$69.1bNT$5.9b21.2x
Sat, 10 Aug 2019NT$228.5bNT$73.2bNT$7.4b21.6x
Median PE Ratio

19.8x


Total Market Cap: NT$230.5bTotal Earnings: NT$7.4bTotal Revenue: NT$73.2bTotal Market Cap vs Earnings and Revenue0%0%0%
Taiwanese Pharma Industry Median PE3Y Average 20.1x202020212022
Current Industry PE
  • Investors are optimistic on the industry, and appear confident in long-term growth rates.
  • The industry is trading at a PE ratio of 93.6x which is higher than its 3-year average PE of 64.5x.
  • The 3-year average PS ratio of 4.4x is lower than the industry's current PS ratio of 5.3x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have declined 16% per year over the last three years.
  • Meanwhile revenues have remained mostly flat.
  • This means that although sales have remained flat, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Comparison

How does Taiwanese Pharma compare with similar industries?

TW Market-2.33%
Healthcare0.34%
Pharma0.44%
Pharma0.44%
Industry PEThere is insufficient data on the sub-industries of this industry.
Forecasted GrowthThere is insufficient data on the sub-industries of this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
1795 Lotus PharmaceuticalNT$153.505.9%
+NT$2.2b
49.8%PE28.7x
6472 Bora PharmaceuticalsNT$266.0012.2%
+NT$2.0b
20.6%PE30.5x
6586 CHO PharmaNT$170.504.6%
+NT$1.4b
354.7%PS8788.7x
1760 Panion & Bf BiotechNT$120.0013.2%
+NT$1.2b
22.0%PE61x
4123 Center LaboratoriesNT$60.202.9%
+NT$858.6m
-3.6%PE28.8x
Simply Wall St
Simply Wall Street Pty Ltd
17-21 Bellevue Street, Surry Hills, Sydney
Download on the App StoreGet it on Google Play
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News